Nebulizer is device used for medication, which converts the liquid into fine mist under pressurized air pump. It uses oxygen, compressed air or ultrasonic power to break medication solutions and deliver a therapeutic dose of aerosol particles directly to the lungs

The report titled “Global Nebulizer Market - Growth, Share, Opportunities and Competitive Analysis, 2016–2022” offers strategic insights into the overall Nebulizer market along with the market size and estimates for the duration 2016 to 2022. The said research study covers in-depth analysis of multiple market segments based on type of device, type of end users, and different geographical region. The device type segment studied for analyzing the overall Nebulizer market is majorly segmented into Pneumatic nebulizer, Ultrasonic nebulizer and Mesh nebulizer. On the type of End User, the Nebulizer market is segmented into Home, Hospital and Physician/ Clinic.

In order to help strategic decision makers, the report also includes competitive profiling of the leading players in Nebulizer market, attractive investment proposition market positioning of key manufacturers sections. Other in-depth analysis provided in the report includes:

Geographically, the global Nebulizer market is studied for the following regional markets:

• North America
  • U.S.
  • Canada
• Europe
  • U.K.
  • Germany
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • Rest of Asia Pacific
• Latin America
• Middle East and Africa

Market size and forecast for these regional and country level markets are presented in this study for the period 2013-2022. Market growth rates for the forecast period 2016-2022 are also included in this report, considering 2015 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global Nebulizer market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global Nebulizer market. This report concludes with company profiles section that highlights major information about the key players engaged in global Nebulizer market. In-depth competitive environment analysis and historical years (2013 & 2014) market size data are also provided in the report.

Thus, the research study provides a holistic view of the global Nebulizer market, offering market size and estimates for the period from 2016 to 2022, keeping in mind the above-mentioned factors.

Based on the type of device, the Global Nebulizer Market is segmented as follows:

• Pneumatic Nebulizer
  • Breathe-Actuated Pneumatic Nebulizer
  • Vented Actuated Pneumatic Nebulizer
• Ultrasonic Nebulizer
• Mesh Nebulizer
  • Static Mesh Nebulizer
  • Vibrating Mesh Nebulizers

Nebulizer market is medical device used for treatment of respiratory diseases such as asthma, COPD and cystic fibrosis. It converts the medical solution into aerosol with different technology, that can be easily inhaled into the lower respiratory tract.  The advancement of technology has segmented nebulizer market into three types Pneumatic, Ultrasonic and Mesh nebulizer. Amongst all, the Pneumatic nebulizer occupies the major share market i.e. 63.83% , followed by the Mesh and Ultrasonic nebulizer. Pneumatic nebulizer is the most commonly used due to easy usage, efficiency and cost benefit. It is further categorized into Breathe-Actuated Pneumatic Nebulizer and Vented Actuated Pneumatic Nebulizer. Breathe-Actuated Pneumatic Nebulizer generates and delivers  according to inspiratory manoeuvre of the patient, leading to economic usage of the drug. The Vented Actuated Pneumatic Nebulizer produces continuous during inspiratory and expiratory and breath holding act. Ultrasonic nebulizer make use of piezoelectric crystal vibration of high frequencies (1-3 MHz) to generate aerosol. It is easy to use, efficient and drug delivery is faster. The Vented Actuated Pneumatic Nebulizer occupies 60.2% market share of the Pneumatic Nebulizer market. With recent development, Mesh nebulizer has entered market, which generates the mist with help of micro pump. Mesh nebulizer use two different techniques to produce mist, therefore further segregated into Static and Vibrating Mesh Nebulizer. According to its name, Static Mesh Nebulizer with aid of static sieving mesh through which the liquid medication is passed through by pressure produce the mist. Vibrating Mesh Nebulizer uses mesh deformation or vibration to pass the liquid medication through the mesh, which occupies major share in mesh nebulizer. Mesh nebulizer is the fastest growing CAGR of 7.2% in 2013-2022 in nebulizer market.

Based on the type of End User, the Global Nebulizer Market is segmented as follows:

• Home
• Hospital
• Physician/Clinic

Global Nebulizer Market is segmented as mentioned above on the basis of the End user. With awareness of treatment of respiratory diseases among patient and with advancement in technology in nebulizer market has caused surge in home care and self medication among patient in North America, Europe and developed nations of

Asia-Pacific.  Home care facility is preferred by the patient over hospital and clinical care especially for chronic and acute respiratory due to novel technology available in the market which is user friendly, portable, efficient and affordable.  Thus the home care segment occupies the major share in the end user segment, and also fastest growing segment, followed by the physician. Other reason being the rising cost of hospitalization and resultant high expenditure led to rise in the home healthcare segment. The physician/clinic segment is anticipated to grow at a steady rate during the forecast period due to the convenience, accessibility, and affordability to the consumers. In the under developed and developing nations people still opt for physicians and clinics for the treatment of various diseases including respiratory conditions. The prime factor for this includes the low awareness about the disease, lesser knowledge about the first line treatment and negligible penetration of the nebulizer devices to the masses. Thus, physician/clinic end-user segment is expected to growth at a steady rate during the forecast period.

For the purpose of this study, the Global Nebulizer Market is categorized into:

• North America
• Europe
• Asia Pacific
• Latin America (LATAM)
• Middle East and Africa (MEA)

In base year 2015, North America accounted for the largest share in terms of 36%, in which US occupies major part, mainly due to key drivers such as surge in diagnosis rates and availability of sophisticated healthcare infrastructure and reimbursement system. Other factors, such as an awareness among the patient population, high government funding and extensive R&D investment in respiratory device market aiming at innovation and rapid commercialization of novel therapeutic and disease management products. On other hand, Asia-Pacific CEA market is expected to grow at CAGR of 8.3% throughout the forecast period 2016 to 2023. The major factors assisting the exponential growth of this region are increasing prevalence of asthma, COPD and other chronic respiratory diseases, pollution and life style change. According to WHO reports the second most prominent cause of death in China is respiratory disease and in India also 12 million people are affected by COPD. Thus Asia Pacific market include rapid urbanization, changing lifestyle, increasing proportion of tobacco smokers and growing healthcare expenditure